Skip to main content
. 2018 Nov 15;13(11):e0207293. doi: 10.1371/journal.pone.0207293

Fig 2.

Fig 2

Course of (A) sphingosine, (B) sphinganine, (C) sphinganine-1-phosphate, (D) C16-dihydroceramide (C16DHC), (E) C18- and (F) C20-ceramide (C18/C20Cer) in patients with no virologic events from baseline (BL) over a follow-up (FU) period of four years (1–4). While C18Cer levels decrease, all other sphingolipid parameters are continuously increasing over time. Statistically significant differences are indicated by asterisks. "*"p<0.05, "**"p<0.01, "***"p<0.001. Bars depict mean +/- standard mean error.